| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 2,150,520 | 1,544,065 | | Cost of Revenue | 1,715,458 | 1,451,704 | | | Gross Profit | 435,062 | 92,361 | | | Operating Expenses | | Research Development | 40,275 | 78,790 | | Selling General and Administrative | 158,439 | 90,245 | | Non Recurring | 612,745 |
-
| | Others | 264,197 | 9,705 | | | | Total Operating Expenses | 1,075,656 |
-
| | | | Operating Income or Loss | (640,594) | (86,379) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (368,178) | 3,980 | | Earnings Before Interest And Taxes | (1,008,772) | (82,399) | | Interest Expense | 31,909 | 796 | | Income Before Tax | (1,040,681) | (83,195) | | Income Tax Expense | (96,680) | 2,105 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (944,001) | (85,300) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (944,001) | (85,300) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($944,001) | ($85,300) |
|
1.23% Nasdaq 
0.06 (0.31%) 
Income Statement
